|
|
|
| Meta analysis on prevalence of anxiety and depression of patients with polycystic ovary syndromen in China |
| YAN Xin WANG Lianhong GUO Yunmei LIU Ying DING Rui #br# |
School of Nursing, Zunyi Medical University, Guizhou Province, Zunyi 563000, China
|
|
|
|
Abstract Objective To understand the anxiety and depression of patients with polycystic ovary syndrome (PCOS) in China. Methods The databases includes CNKI, Wanfang Data Knowledge Service Platform, VIP, CBM, PubMed, EMbase, The Cochrane Library, and Web of Science core collection were searched by computer, the retrieval time was from the database construction to September 2021. The investigation and research on the anxiety and depression of PCOS patients in China were collected. The prevalence of anxiety and depression was analyzed using Stata 12.0 software. Results A total of nine literatures were included. Meta analysis showed that the prevalence of anxiety in PCOS patients in China was 22% (95%CI: 20%-24%), and the prevalence of depression was 30% (95%CI: 28%-32%). Subgroup analysis showed that the prevalence of PCOS anxiety was 24% (95%CI: 21%-27%) and the prevalence of depression depression was 28% (95%CI: 26%-31%) in recent five years; the prevalence of PCOS anxiety and depression was 16% (95%CI: 11%-21%) and the prevalence of depression was 30% (95%CI: 24%-36%) in recent five to ten years; the prevalence of PCOS anxiety was 23% (95%CI: 19%-27%), and the prevalence of depression was 37% (95%CI: 32%-42%) over ten years. The prevalence of anxiety was 30% (95%CI: 25%-36%) and the prevalence of depression was 29% (95%CI: 23%-34%) in South China; the prevalence of anxiety was 27% (95%CI: 22%-32%) and the prevalence of depression was 38% (95%CI: 33%-42%) in North China; the prevalence of anxiety was 16% (95%CI: 13%-20%) and the prevalence of depression was 33% (95%CI: 29%-38%) in East China; the prevalence of anxiety was 22% (95%CI: 19%-26%) and the prevalence of depression was 24% (95%CI: 21%-28%) in Southwest China. Conclusion Anxiety and depression in PCOS patients in China are in a high incidence trend. Therefore, it is necessary to strengthen the management of PCOS patients’ adverse emotions to explore effective emotional management means by both prevention and intervention.
|
|
|
|
|
|
[1] Azziz R，Carmina E，Chen Z，et al. Polycystic ovary syndrome [J]. Nat Rev Dis Primers，2016，2：16057.
[2] Copp T，Muscat DM，Hersch J，et al. The challenges with managing polycystic ovary syndrome：A qualitative study of women’s and clinicians’ experiences [J]. Patient Educ Couns，2022,105（3）：719-725.
[3] 谯小勇，靳松，杨业洲.多囊卵巢综合征长期并发症早防早治新策略[J].中国计划生育和妇产科，2020，12（2）：13-18.
[4] Brutocao C，Zaiem F，Alsawas M，et al. Psychiatric disorders in women with polycystic ovary syndrome：a systematic review and meta-analysis [J]. Endocrine，2018，62（2）：318-325.
[5] Cooney LG，Lee I，Sammel MD，et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome：a systematic review and meta-analysis [J]. Hum Reprod，2017，32（5）：1075-1091.
[6] 谭秋晓，张红梅，李洁明，等.多囊卵巢综合征患者抑郁和焦虑发病现状及影响因素分析[J].实用医学杂志，2020， 36（23）：3288-3292.
[7] 董惠娟，张丹英，俞超芹，等.多囊卵巢综合征患者焦虑和抑郁状况的调查[J].中华现代护理杂志，2012，18（10）：1189-1190.
[8] 虞一萍，张敏，徐鸣，等.多囊卵巢综合征患者情绪障碍研究[J].中国临床医学，2013，20（3）：343-345.
[9] 鞠慧岩，陈菲，郑修霞，等.多囊卵巢综合征病人负性情绪的调查分析[J].护理研究，2008，22（24）：2168-2170.
[10] 田艳，邹涛，黄永俐，等.PCOS并不孕症患者性激素水平及胰岛素抵抗与不良情绪的关系[J].贵州医科大学学报，2019，44（11）：1316-1319，1329.
[11] 葛丽，石玉华，郝翠芳，等.Increased risk of psychiatric disorders in Chinese women with polycystic ovary syndrome[J].生殖医学杂志，2010，19（z2）：8-14.
[12] Tan J，Wang QY，Feng GM，et al. Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China [J]. Chin Med J （Engl），2017，130（3）：262-266.
[13] Yang Y，Deng H，Li T，et al. The mental health of Chinese women with polycystic ovary syndrome is related to sleep disorders，not disease status [J]. J Affect Disord，2021，282：51-57.
[14] 冯静，高芳圆，奚杰.多囊卵巢综合征并发抑郁的危险因素分析[J].中华内分泌外科杂志，2018，12（3）：247-250.
[15] Huang Y，Wang Y，Wang H，et al. Prevalence of mental disorders in China：a cross-sectional epidemiological study [J]. Lancet Psychiatry，2019，6（4）：e11.
[16] Conte F，Banting L，Teede HJ，et al. Mental health and physical activity in women with polycystic ovary syndrome：a brief review [J]. Sports Med，2015，45（4）：497-504.
[17] Ethirajulu A，Alkasabera A，Onyali CB，et al. Insulin Resistance，Hyperandrogenism，and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome [J]. Cureus，2021，13（9）：e18013.
[18] de Wit AE，Giltay EJ，de Boer MK，et al. Plasma androgens and the presence and course of depression in a large cohort of women [J]. Transl Psychiatry，2021，11（1）：124.
[19] 潘雪，刘雁峰，梁嘉玲，等.多囊卵巢综合征与心理应激的相关性研究进展[J].中国妇幼保健，2019，34（21）：5078-5081.
[20] 中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志，2018， 53（1）：2-6.
[21] Meng Q，Ren A，Zhang L，et al. Incidence of infertility and risk factors of impaired fecundity among newly married couples in a Chinese population [J]. Reprod Biomed Online，2015，30（1）：92-100.
[22] Ee C，Smith C，Moran L，et al. “The whole package deal”：experiences of overweight/obese women living with polycystic ovary syndrome [J]. BMC Womens Health，2020， 20（1）：221.
[23] Jiskoot G，Dietz de Loos A，Beerthuizen A，et al. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome（PCOS）：A secondary analysis of a randomized controlled trial [J]. PLoS One，2020，15（6）：e233876.
[24] Arentz S，Smith CA，Abbott J，et al. Perceptions and experiences of lifestyle interventions in women with polycystic ovary syndrome（PCOS），as a management strategy for symptoms of PCOS [J]. BMC Womens Health，2021， 21（1）：107.
[25] Light RS，Chilcot J，McBride E. Psychological Distress in Women Living with Polycystic Ovary Syndrome：The Role of Illness Perceptions[J]. Womens Health Issues，2021，31（2）：177-184. |
|
|
|
